Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06415461 · ClinicalTrials.gov registry record · Phase 1
A Study Assessing the Safety of Cord Blood Product in Sacroiliac Joint Syndrome (SIJ)
A Phase 1 study of Pain, Back and Sacroiliac; Backache, sponsored by University of Florida.
- Active
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT06415461: Active Phase 1 study of Pain, Back and Sacroiliac; Backache, sponsored by University of Florida.
NCT06415461 is a Phase 1 study of Pain, Back and Sacroiliac; Backache that is active but no longer recruiting, run by University of Florida. The registered enrollment target is 9 participants, below the 331-participant average among 7 other Pain, Back trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06415461, a Phase 1 study of Pain, Back and Sacroiliac; Backache, is active but no longer recruiting, sponsored by University of Florida.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a Phase 1 trial. The overall objective is to evaluate the safety and potential efficacy effect of specific type of umbilical cord blood product (CFL001), which, other than specific modifications in manufacturing to render it compatible with current Good Manufacturing Practice (cGMP), is essentially similar to that reported in real-world experience.
Primary Outcome
All Adverse events (types and frequencies) will be collected for all patients. Protocol defined study endpoints will also be collected on all patients. Study endpoints include: • Stopping criteria as defined in protocol
Conditions Studied
Interventions
- BIOLOGICAL PremierMaxCB®-Platinum (CFL001);
Study Locations (1)
Florida
- University of Florida Pain Clinic - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2024-05-10 |
| Est. Completion | 2028-03-06 |
| Phase | Phase 1 |
What the registry record for NCT06415461 still lists
NCT06415461 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 331-participant average among 7 other Pain, Back trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Pain, Back appearing as the primary indexed condition, and to 1 intervention - of which PremierMaxCB®-Platinum (CFL001); is the first listed.
NCT06415461 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06415461 about?
NCT06415461 is a clinical study titled "A Study Assessing the Safety of Cord Blood Product in Sacroiliac Joint Syndrome (SIJ)". This is a Phase 1 trial. The overall objective is to evaluate the safety and potential efficacy effect of specific type of umbilical cord blood product (CFL001), which, other than specific modifications in manufacturing to render it compatible with current Good Manufacturing Practice (cGMP), is esse...
What is the current status of trial NCT06415461?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2024-05-10. Estimated completion is 2028-03-06.
What conditions does trial NCT06415461 study?
This clinical trial studies the following conditions: Pain, Back, Sacroiliac; Backache.
What interventions are being tested in trial NCT06415461?
The interventions under investigation include: PremierMaxCB®-Platinum (CFL001); (BIOLOGICAL).
Who is sponsoring clinical trial NCT06415461?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06415461 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Back
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
RECRUITING · Phase 3
-
PREventing Pain After Surgery
RECRUITING · NA
-
Trigger Point Injections in Anterior Cervical Surgery
RECRUITING · Phase 4
-
Regional Nerve Blocks to Improve Analgesia and Recovery in Older Adults Undergoing Spinal Fusion
RECRUITING · Early Phase 1
-
Brown Adipose Tissue Activation by Spinal Cord Stimulation
RECRUITING · NA
-
Implementation of the ACP Guideline for Low Back Pain (IMPACt-LBP)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI